Skip to main content
. 2021 Jul 29;11(8):748. doi: 10.3390/jpm11080748

Table 1.

Comparison of the training and testing sets.

Variables Training Set (n = 1328) Testing Set (n = 332) p Value
Male, n (%) 983 (74.0%) 242 (72.9%) 0.626
Age, mean (SD), years 58.94 (9.80) 59.66 (10.71) 0.242
BMI, mean (SD), kg/m2 21.01 (2.65) 21.02 (2.76) 0.930
Hypertension, n (%) 312 (23.5%) 67 (20.2%) 0.214
Diabetes, n (%) 88 (6.6%) 23 (6.9%) 0.807
Previous abdominal surgery, n (%) 260 (19.6%) 60 (18.1%) 0.586
Brinkman index, mean (SD) 221.34 (412.59) 199.94 (316.26) 0.388
Alcohol use, n (%) 272 (20.5%) 64 (19.3%) 0.648
Hemoglobin, mean (SD), g/L 119.96 (22.17) 120.24 (23.73) 0.839
Albumin, mean (SD), g/L 38.46 (4.57) 38.74 (4.90) 0.325
Tumor size, mean (SD), cm 4.34 (2.33) 4.36 (2.40) 0.881
Tumorous obstruction, n (%) 226 (17.0%) 58 (17.5%) 0.871
Neoadjuvant, n (%) 33 (2.5%) 7 (2.1%) 0.842
Total gastrectomy, n (%) 898 (67.6%) 237 (71.4%) 0.210
Esophagogastrostomy, n (%) 424 (31.9%) 89 (26.8%) 0.073
Combined resection, n (%) 68 (5.1%) 21 (6.3%) 0.413
Laparoscopic surgery, n (%) 1133 (85.3%) 283 (85.2%) 1.000
Blood loss, mean (SD), ml 146.95 (252.80) 140.66 (222.05) 0.678
Intraperitoneal chemotherapy, n (%) 979 (73.7%) 254 (76.5%) 0.326
Nasogastric tube, n (%) 1305 (98.3%) 323 (97.3%) 0.263
Indwelling drainage tube, n (%) 1317 (99.2%) 325 (97.9%) 0.068
Operative time, mean (SD), minutes 304.28 (60.71) 312.17 (63.11) 0.036
ASA 0.083
  1 205 (15.4%) 48 (14.5%)
  2 971 (73.1%) 233 (70.2%)
  3 145 (10.9%) 51 (15.4%)
  4 7 (0.5%) 0 (0.0%)
Clinical stages 0.353
  1 200 (15.0%) 49 (14.8%)
  2 454 (34.2%) 108 (32.5%)
  3 608 (45.8%) 150 (45.2%)
  4 66 (5.0%) 25 (7.5%)
AL 25 (1.9%) 11 (3.3%) 0.087

SD, standard deviation; BMI, body mass index; ASA, American Society of Anesthesiologists score; AL, anastomotic leakage.